melaleuca alternifolia oil
australian pesticides and veterinary medicines authority - melaleuca alternifolia oil - unknown - melaleuca alternifolia oil oil-plant extract active 0.0 - active constituent
acquired genetic alteration ivds
bio-rad laboratories pty ltd - ct929 - acquired genetic alteration ivds - ivds that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information.
pressure alleviation pad, air, alternating contact, <specify>
solari medical -
38483 - pressure alleviation pad, air, alternating contact,
hybrid mattress sysyem - alternating-pressure bed mattress system
safety and mobility pty ltd - 63241 - alternating-pressure bed mattress system - hybrid alternating pressure pad/ bed mattress system mattress with two forms of pressure control: (1) a powered control pump designed to alternate air pressure in individual cells for pressure sore prevention. (2) a non-powered regulated static care breather valve to allow free movement of air between cells, thus causing the air in the cells to move with patient movement for pressure sore prevention.
pressure alleviation pad, air, alternating contact, control unit
kd & a pty ltd - 36688 - pressure alleviation pad, air, alternating contact, control unit - a device used to power an alternating pressure therapeutic mattress.
ohm allergy mold mix- alternaria alt, aspergillus fum, aspergillus nig, boletus sat, botrytis cin, candida alb, cladosporium met
ohm pharma inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), boletus satanas fruiting body (unii: 68og1407sm) (boletus satanas fruiting body - unii:68og1407sm), botrytis cinerea (unii: tbw53313s7) (botrytis cinerea - unii:tbw53313s7), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21h - uses: temporarily relieves sneezing, runny nose, itchy eyes associated with exposure to molds and fungi.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.
candida spp- alternaria tenuis nees, aspergillus niger, candida albicans, candida parapsilosis, mucor racemosus, pullularia pull
deseret biologicals, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc), candida parapsilosis (unii: 0kz676d44n) (candida parapsilosis - unii:0kz676d44n), mucor racemosus (unii: 17rh99lq7g) (mucor racemosus - unii:17rh99lq7g), aureobasidium pullulans var. pullutans (unii: d1a2ng69ck) (aureobasidium pullulans var. pullutans - for temporary relief of symptoms related to various forms of candida spp. overgrowth such as nausea, drowsiness, lethargy, confusion, vaginal discharge, sensitivities to foods and mucous congestion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to various forms of candida spp. overgrowth such as nausea, drowsiness, lethargy, confusion, vaginal discharge, sensitivities to foods and mucous congestion.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.
a-21- alternaria alternata, aspergillus niger var. niger, cochliobolus spicifer, gibberella fujikuroi, cochliobolus sativus, cla
dna labs, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), cochliobolus spicifer (unii: 91m9rwp3td) (cochliobolus spicifer - unii:91m9rwp3td), gibberella fujikuroi (unii: 815v716or2) (gibberella fujikuroi - unii:815v716or2), cochliobolus sativus (unii: 3ln5b70u4w) (cochliobolus sativus - unii:3ln5b70u4w), cladosporium bruhnei (unii: r1786y8h66) (cladosporium bruhnei - unii:r1786y8h6 - allergies.
allergy atlantic mold mix- alternaria alternata, aspergillus fumigatus, botrytis cinerea, rhizopus stolonifer, ustilago maydis l
natural creations, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), botrytis cinerea (unii: tbw53313s7) (botrytis cinerea - unii:tbw53313s7), rhizopus stolonifer (unii: fee198dk4q) (rhizopus stolonifer - unii:fee198dk4q), ustilago maydis (unii: 4k7z7k7swg) (ustilago maydis - unii:4k7z7k7swg) - uses : temporarily relieves symptoms related to mold allergies.** uses : temporarily relieves symptoms related to mold allergies.**
mold mix a- alternaria alternata, aspergillus fumigatus, cladosporium cladosporioides and penicillium chrysogenum var. chrysogen
alk-abello, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48), cladosporium cladosporioides (unii: 4zwy20gtgo) (cladosporium cladosporioides - unii:4zwy20gtgo), penicillium chrysogenum var. chrysogenum (unii: 3y1pe1gcig) (penicillium chrysogenum var. chrysogenum - unii:3y1pe1gcig) - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater